Tirzepatide and next-gen GLP-1s can convert obesity from affliction to choice, with proven cardiovascular benefits and emerging data on kidney, liver, Alzheimer's, and addiction (smoking, a…

Cut preclinical time from 4-5 years to 2.5, clinical from 10 to 5.9 years via parallel manufacturing and pre-specified decision gates; structural advantage if repeatable across pipeline.

Diffusion models suggest novel chemical starting points in 10^60 molecular space, augmenting chemist creativity; long-term potential to accelerate lead optimization but requires wet-lab val…

Small AI intervention in production bottleneck increased output 7-8%, worth hundreds of millions to billions in revenue; digital control of manufacturing enables faster changes vs physical…

China reduced drug lag from 7 years to under 12 months vs US with regulatory harmonization, while Europe's 2.5-year post-approval delay wastes patent life; China aims to be first launch mar…